← Eichor
Condition: De Novo Multiple Myeloma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: De Novo Multiple Myeloma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)
Phase 2 · 10 location(s) · PETHEMA Foundation · NCT070459093'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma
NA · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06474182Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137643Biomarkers in Multiple Myeloma
NA · 2 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT05259553
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.